Article
Identification of mutations and polymorphisms in the factor XI genes of an African American family by dideoxyfingerprinting.
Department of Pediatrics, Pathology, and Medicine, Vanderbilt University, Nashville, TN, USA.
Blood (impact factor:
9.9).
12/1998;
92(9):3309-17.
pp.3309-17
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Molecular genetic analysis of severe coagulation factor XI deficiency in six Italian patients.
[show abstract] [hide abstract]
ABSTRACT: Factor XI (FXI) deficiency is a rare autosomal recessive coagulopathy which is, however, frequent among Ashkenazi Jews. Two mutations, type II (Glu117stop) and type III (Phe283Leu), account for the majority of abnormal alleles in this population. The aim of this study was to analyze the molecular basis of FXI deficiency in six unrelated Italian probands with severe deficiency, a population hitherto largely unexplored. All patients showed unmeasurable functional FXI levels in plasma. Mutational screening was performed by sequencing. Haplotype analysis was performed using intragenic polymorphisms. Expression studies were performed by transient transfection in COS-1 cells. Sequencing identified two novel mutations: a nonsense mutation (Cys118stop) in exon 5 in two probands, and a 6-bp deletion (643-648delATCGAC) in exon 7 in one proband. The Cys118stop is predicted to cause FXI deficiency by a secretion defect and/or by increased mRNA degradation. The 6-bp deletion causes the loss of residues Ile197 and Asp198. There was a remarkable secretion impairment of the deleted FXI protein. In four of the six probands, the type II mutation was found. Haplotype analysis in patients carrying the type II mutation revealed that they share a common haplotype, perhaps derived from a Jewish ancestor. The identification and characterization of two novel mutations widen the mutational spectrum of FXI deficiency. Haplotype analysis is compatible with a Jewish origin of the type II mutation. The high occurrence of the type II mutation among Italian patients will be helpful to direct future genetic screenings.Haematologica 12/2004; 89(11):1332-40. · 6.42 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
9-year-old boy
abnormal molecules
additional mutation
African American patients
amino acid changes
amino acid substitutions
bleeding disorder
ethnic groups
exon 8
factor IX
Factor XI circulates
factor XI gene
factor XI genes
factor XI heavy chain
glutamine 226
normal volunteers
rare condition
T change
third apple domain
two abnormal gene products